SCHEMBL19733016

SCHEMBL19733016

C=CCON([C@H]1CN(C(=O)OC(C)(C)C)[C@@H](C(N)=O)C=C1C)S(=O)(=O)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 3/20 0.33
MET P08581 2/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 2/20 0.33
GAA P10253 1/20 0.33
F13A1 P00488 1/20 0.32
TGM2 P21980 1/20 0.32
TGM1 P22735 1/20 0.32
F2 P00734 2/20 0.32
PRSS1 P07477 1/20 0.32
PRSS2 P07478 1/20 0.32
PRSS3 P35030 1/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
BTK Q06187 2/20 0.31
CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29593595 1.00 NPC1 (0.35) NPC1MEN1KMT2AALDH1A1MET
SCHEMBL16552757 1.00 NPC1 (0.35) NPC1MEN1KMT2AALDH1A1MET
SCHEMBL19733015 1.00 NPC1 (0.35) NPC1MEN1KMT2AALDH1A1MET
SCHEMBL15319706 1.00 NPC1 (0.35) NPC1MEN1KMT2AALDH1A1MET
SCHEMBL15319507 0.93 KMT2A (0.36) MEN1KMT2AALDH1A1METMAPT
SCHEMBL29759103 0.93 KMT2A (0.36) MEN1KMT2AALDH1A1METMAPT
SCHEMBL31286129 0.93 KMT2A (0.36) MEN1KMT2AALDH1A1METMAPT
SCHEMBL16552990 0.92 NR1H2 (0.35) MEN1KMT2AALDH1A1METMAPT
SCHEMBL15319628 0.92 NR1H2 (0.35) MEN1KMT2AALDH1A1METMAPT
SCHEMBL28718792 0.91 NPC1 (0.37) NPC1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2834239-B1 HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS ENTASIS THERAPEUTICS LTD (GB) 2017-12-27 EP disclosed